The female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Algeria is now 12.8%, marking a 0.3% (2.4%) increase compared to 2020.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Algeria
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Algeria
Out-of-pocket expenditure PPP per capita
intl dollar274
-intl dollar3
(2022)
Newborns protected against tetanus
97%
0%
(2023)
Female wasting in children
2.4%
-1.4%
(2019)
Birth registration
99.6%
0%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
44.9%
-3%
(2019)
Algeria Female CVD, cancer, diabetes or CRD between 2000 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 12.8% | +0.3% |
| 2020 | 12.5% | -0.3% |
| 2019 | 12.8% | 0% |
| 2018 | 12.8% | 0% |
| 2017 | 12.8% | -0.1% |
| 2016 | 12.9% | -0.2% |
| 2015 | 13.1% | -0.1% |
| 2014 | 13.2% | -0.3% |
| 2013 | 13.5% | -0.2% |
| 2012 | 13.7% | -0.3% |
| 2011 | 14% | -0.1% |
| 2010 | 14.1% | -0.3% |
| 2009 | 14.4% | -0.3% |
| 2008 | 14.7% | -0.2% |
| 2007 | 14.9% | -0.3% |
| 2006 | 15.2% | -0.2% |
| 2005 | 15.4% | -0.2% |
| 2004 | 15.6% | -0.2% |
| 2003 | 15.8% | -0.2% |
| 2002 | 16% | -0.2% |
| 2001 | 16.2% | -0.2% |
| 2000 | 16.4% |